AAAAAA

   
Results: 1-12 |
Results: 12
TUMOR-TARGETED APOPTOSIS BY A NOVEL SPERMINE ANALOG, 1,12-DIAZIRIDINYL-4,9-DIAZADODECANE, RESULTS IN THERAPEUTIC EFFICACY AND ENHANCED RADIOSENSITIVITY OF HUMAN PROSTATE-CANCER
Authors: EISEMAN JL ROGERS FA GUO YP KAUFFMAN J SENTZ DL KLINGER MF CALLERY PS KYPRIANOU N
Citation: Jl. Eiseman et al., TUMOR-TARGETED APOPTOSIS BY A NOVEL SPERMINE ANALOG, 1,12-DIAZIRIDINYL-4,9-DIAZADODECANE, RESULTS IN THERAPEUTIC EFFICACY AND ENHANCED RADIOSENSITIVITY OF HUMAN PROSTATE-CANCER, Cancer research, 58(21), 1998, pp. 4864-4870
METABOLISM OF 17-(ALLYLAMINO)-17-DEMETHOXYGELDANAMYCIN (NSC-330507) BY MURINE AND HUMAN HEPATIC PREPARATIONS
Authors: EGORIN MJ ROSEN DM WOLFF JH CALLERY PS MUSSER SM EISEMAN JL
Citation: Mj. Egorin et al., METABOLISM OF 17-(ALLYLAMINO)-17-DEMETHOXYGELDANAMYCIN (NSC-330507) BY MURINE AND HUMAN HEPATIC PREPARATIONS, Cancer research, 58(11), 1998, pp. 2385-2396
IN-VITRO METABOLISM BY MOUSE AND HUMAN LIVER PREPARATIONS OF HALOMON,AN ANTITUMOR HALOGENATED MONOTERPENE
Authors: EGORIN MJ ROSEN DM BENJAMIN SE CALLERY PS SENTZ DL EISEMAN JL
Citation: Mj. Egorin et al., IN-VITRO METABOLISM BY MOUSE AND HUMAN LIVER PREPARATIONS OF HALOMON,AN ANTITUMOR HALOGENATED MONOTERPENE, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 9-14
PLASMA PHARMACOKINETICS, BIOAVAILABILITY, AND TISSUE DISTRIBUTION IN CD2F1 MICE OF HALOMON, AN ANTITUMOR HALOGENATED MONOTERPENE ISOLATED FROM THE RED ALGAE PORTIERIA-HORNEMANNII
Authors: EGORIN MJ SENTZ DL ROSEN DM BALLESTEROS MF KEARNS CM CALLERY PS EISEMAN JL
Citation: Mj. Egorin et al., PLASMA PHARMACOKINETICS, BIOAVAILABILITY, AND TISSUE DISTRIBUTION IN CD2F1 MICE OF HALOMON, AN ANTITUMOR HALOGENATED MONOTERPENE ISOLATED FROM THE RED ALGAE PORTIERIA-HORNEMANNII, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 51-60
PLASMA PHARMACOKINETICS AND URINARY-EXCRETION OF THE POLYAMINEANALOGUE 1,19-BIS(ETHYLAMINO)-5,10,15-TRIAZANONADECANE IN CD2F1 MICE
Authors: EISEMAN JL YUAN ZM EDDINGTON ND SENTZ DL GALLERY PS EGORIN MJ
Citation: Jl. Eiseman et al., PLASMA PHARMACOKINETICS AND URINARY-EXCRETION OF THE POLYAMINEANALOGUE 1,19-BIS(ETHYLAMINO)-5,10,15-TRIAZANONADECANE IN CD2F1 MICE, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 13-20
SYNTHESIS AND ANTITUMOR EVALUATION OF A HIGHLY POTENT CYTOTOXIC DNA CROSS-LINKING POLYAMINE ANALOG, 1,12-DIAZIRIDINYL-4,9-DIAZADODECANE
Authors: LI YL EISEMAN JL SENTZ DL ROGERS FA PAN SS HU LT EGORIN MJ CALLERY PS
Citation: Yl. Li et al., SYNTHESIS AND ANTITUMOR EVALUATION OF A HIGHLY POTENT CYTOTOXIC DNA CROSS-LINKING POLYAMINE ANALOG, 1,12-DIAZIRIDINYL-4,9-DIAZADODECANE, Journal of medicinal chemistry, 39(1), 1996, pp. 339-341
T-CELL LYMPHOMAS ARISE IN LATE-STAGE LP-BM5 MULV INFECTED MICE
Authors: EISEMAN JL CAMPBELLWASHINGTON J SENTZ DL
Citation: Jl. Eiseman et al., T-CELL LYMPHOMAS ARISE IN LATE-STAGE LP-BM5 MULV INFECTED MICE, AIDS research and human retroviruses, 11, 1995, pp. 143-143
RETINOIC ACID NUCLEAR RECEPTOR-BETA INHIBITS BREAST-CARCINOMA ANCHORAGE-INDEPENDENT GROWTH
Authors: LI XS SHAO ZM SHEIKH MS EISEMAN JL SENTZ D JETTEN AM CHEN JC DAWSON MI AISNER S RISHI AK GUTIERREZ P SCHNAPPER L FONTANA JA
Citation: Xs. Li et al., RETINOIC ACID NUCLEAR RECEPTOR-BETA INHIBITS BREAST-CARCINOMA ANCHORAGE-INDEPENDENT GROWTH, Journal of cellular physiology, 165(3), 1995, pp. 449-458
PLASMA PHARMACOKINETICS AND TISSUE DISTRIBUTION OF PACLITAXEL IN CD2F1 MICE
Authors: EISEMAN JL EDDINGTON ND LESLIE J MACAULEY C SENTZ DL ZUHOWSKI M KUJAWA JM YOUNG D EGORIN MJ
Citation: Jl. Eiseman et al., PLASMA PHARMACOKINETICS AND TISSUE DISTRIBUTION OF PACLITAXEL IN CD2F1 MICE, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 465-471
PARTIAL GROWTH SUPPRESSION OF HUMAN PROSTATE-CANCER CELLS BY THE KREV-1 SUPPRESSOR GENE
Authors: BURNEY TL ROCKOVE S EISEMAN JL JACOBS SC KYPRIANOU N
Citation: Tl. Burney et al., PARTIAL GROWTH SUPPRESSION OF HUMAN PROSTATE-CANCER CELLS BY THE KREV-1 SUPPRESSOR GENE, The Prostate, 25(4), 1994, pp. 177-188
IMPACT OF DOSING SCHEDULE UPON SUPPRESSION OF A RETROVIRUS IN A MURINE MODEL OF AIDS ENCEPHALOPATHY
Authors: BILELLO JA EISEMAN JL STANDIFORD HC DRUSANO GL
Citation: Ja. Bilello et al., IMPACT OF DOSING SCHEDULE UPON SUPPRESSION OF A RETROVIRUS IN A MURINE MODEL OF AIDS ENCEPHALOPATHY, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 628-631
IMMUNOMODULATION OF INTERLEUKIN-2 BY CYCLOPHOSPHAMIDE - A PHASE-IB TRIAL
Authors: ABRAMS JS EISEMAN JL MELINK TJ SRIDHARA R HIPONIA DJ BELL MM BELANI CP ADLER WH AISNER J
Citation: Js. Abrams et al., IMMUNOMODULATION OF INTERLEUKIN-2 BY CYCLOPHOSPHAMIDE - A PHASE-IB TRIAL, Journal of immunotherapy with emphasis on tumor immunology, 14(1), 1993, pp. 56-64
Risultati: 1-12 |